Sphingomyelinase and cell-permeable ceramide analogs increase the release of plasminogen activator inhibitor-1 from cultured endothelial cells

By Soeda S.   Honda O.   Shimeno H.   Nagamatsu A.  

Thrombosis Research, Vol. 80, Iss. 6, 1995-12 ,pp. : 509-518

Elsevier

Access to resources Recommend Favorite

HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells

By Kunieda Y.   Nakagawa K.   Nishimura H.   Kato H.   Ukimura N.   Yano S.   Kawano H.   Kimura S.   Nakagawa M.   Tsuji H.  

Thrombosis Research, Vol. 110, Iss. 4, 2003-06 ,pp. : 227-234

Elsevier

Access to resources Recommend Favorite

Urokinase-Type Plasminogen Activator Overexpression Enhances the Invasive Capacity of Endothelial Cells

By Gualandris A.   Conejo T.L.   Giunciuglio D.   Albini A.   Sabini E.   Rusnati M.   dell'Era P.   Presta M.  

Microvascular Research, Vol. 53, Iss. 3, 1997-05 ,pp. : 254-260

Academic Press

Access to resources Recommend Favorite

Urokinase binding and catabolism by Hep G2 cells is plasminogen activator inhibitor-1 dependent, analogous to interactions of tissue-type plasminogen activator with these cells

By Grimsley P.G.   Normyle J.F.   Brandt R.A.   Joulianos G.   Chesterman C.N.   Hogg P.J.   Owensby D.A.  

Thrombosis Research, Vol. 79, Iss. 4, 1995-08 ,pp. : 353-361

Elsevier

Access to resources Recommend Favorite

A NEW BUTADIENE DERIVATIVE, T-686, INHIBITS PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 PRODUCTION IN VITRO BY CULTURED HUMAN VASCULAR ENDOTHELIAL CELLS AND DEVELOPMENT OF ATHEROSCLEROTIC LESIONS IN VIVO IN RABBITS

By Vinogradsky B.   Bell S.P.   Woodcock-Mitchell J.   Ohtani A.   Fujii S.  

Thrombosis Research, Vol. 85, Iss. 4, 1997-02 ,pp. : 305-314

Elsevier

Access to resources Recommend Favorite